Prognostic significance of BCL-2 expression in patients with multiple myeloma.

被引：0
|
作者：
Hashmi, M
Kojouri, K
Yang, J
Patel, S
Khan, M
Sylvester-Kohrt, N
Kamble, R
Selby, GB
Ozer, H
Kharfan-Dabaja, MA
机构：
[1] Univ Oklahoma, Hematol Oncol Sect, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Ctr Canc, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4840
引用
收藏
页码：292B / 293B
页数：2
相关论文
共 50 条
  • [21] Prognostic significance of Bcl-2 and Bcl-6 expression in patients with nodular sclerosis Hodgkin lymphoma (NSHL)
    Naushad, H
    Aoun, P
    Smith, LM
    Pan, Z
    Bierman, P
    Greiner, TC
    Chan, WC
    Weisenburger, DD
    LABORATORY INVESTIGATION, 2006, 86 : 239A - 239A
  • [22] Expression of MDR 1 and bcl-2 genes in leukemias and multiple myeloma
    Cioch, M
    Kocki, J
    Dmoszynska, A
    Hus, I
    Wojtaszko, M
    Koktysz, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 330 - 330
  • [23] Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma
    Zhang, Mingbin
    Zhang, Ping
    Zhang, Chenping
    Sun, Jian
    Wang, Lizhen
    Li, Jiang
    Tian, Zhen
    Chen, Wantao
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (03) : 307 - 313
  • [24] RESPONSE TO INTERFERON THERAPY IN PATIENTS WITH MULTIPLE-MYELOMA CORRELATES WITH EXPRESSION OF THE BCL-2 ONCOPROTEIN
    SANGFELT, O
    OSTERBORG, A
    GRANDER, D
    ANDERBRING, E
    OST, A
    MELLSTEDT, H
    EINHORN, S
    INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (02) : 190 - 192
  • [25] Targeting Bcl-2 for the treatment of multiple myeloma
    Cyrille Touzeau
    Paulo Maciag
    Martine Amiot
    Philippe Moreau
    Leukemia, 2018, 32 : 1899 - 1907
  • [26] Prognostic Significance of BCL-2 and BCL-6 Expression in MYC-positive DLBCL
    Li, Linyu
    Zhang, Xuhan
    Zhang, Tingting
    Song, Zheng
    Hu, Ge
    Li, Wei
    Li, Lanfang
    Qiu, Lihua
    Qian, Zhengzi
    Zhou, Shiyong
    Liu, Xianming
    Feng, Lixia
    Pan, Yi
    Zhai, Qiongli
    Meng, Bin
    Ren, Xiubao
    Fu, Kai
    Wang, Ping
    Wang, Xianhuo
    Zhang, Huilai
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : E381 - E389
  • [27] Targeting Bcl-2 for the treatment of multiple myeloma
    Touzeau, Cyrille
    Maciag, Paulo
    Amiot, Martine
    Moreau, Philippe
    LEUKEMIA, 2018, 32 (09) : 1899 - 1907
  • [28] Bcl-2 antisense therapy in multiple myeloma
    Bloem, A
    Lockhorst, H
    PATHOLOGIE BIOLOGIE, 1999, 47 (02): : 216 - 220
  • [29] The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
    Herod, JJO
    Eliopoulos, AG
    Warwick, J
    Niedobitek, G
    Young, LS
    Kerr, DJ
    CANCER RESEARCH, 1996, 56 (09) : 2178 - 2184
  • [30] Prognostic significance of Bcl-2 and p53 expression in gastric cancer
    Lee, HK
    Lee, HS
    Yang, HK
    Kim, WH
    Lee, KU
    Choe, KJ
    Kim, JP
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2003, 18 (06) : 518 - 525
12345